Adhesys Medical gets CE mark for its topical skin adhesive for surgical use

Adhesys Medical grabs CE mark for its innovative surgical wound adhesive.

Adhesys Medical, a surgical adhesive company, said it has received a CE mark for its Mar-Cutis Flix topical skin adhesive for surgical use.

The adhesive is a polyurethane-based technology the company said is an innovative alternative to traditional wound closing techniques that features bonding strength, fast sealing and high flexibility.

Adhesys was a U.S.-based medical device startup that was acquired by Germany’s Grünenthal Group last April.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

"Having obtained the CE-Certification, we are now looking forward to further developing our technology platform and expanding the possible fields of application,” Klaus-Dieter Langner, chief scientific officer for Grünenthal, said in a statement.

Grünenthal is a pharmaceutical and medical device R&D company with subsidiaries and affiliates in Europe, the U.S. and Latin America and about 5,500 employees. The privately held company reported 2016 revenue of about $1.7 billion.

Suggested Articles

The FDA has cleared its first duodenoscope designed to make the intricate, moving and difficult-to-clean parts in the head of the device disposable.

The FDA has approved its first contact lens designed to effectively slow the progression of nearsightedness in children, starting in ages 8 to 12.

Novartis tapped Biofourmis to develop tracking programs for heart failure patients, as the latter acquired Biovotion, makers of clinical wearables.